Fmoc-(2S,4R)-4-hydroxypiperidine-2-carboxylic acid, 97.0%, 250mg

Tetraheptylammonium Bromide>98.0%(T)5g

4-(Trans-4-Ethylcyclohexyl)-benzonitrile, 98.0%, 100g

5-hydroxy-1,2-dimethyl-4(1H)-pyridinone, 95.0%, 1g

4-(ISOBUTYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 250mg

Ethyl docosa-4,7,10,13,16,19-hexaenoate, 98%, 1g

(2R,4R)-tert-Butyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate, 95%, 250mg

Tucatinib, 99.82%, 250mg

(1R,2S,5S)-6,6-Dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 97%, 250mg

5-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)thiazol-2-amine, 98%, 250mg

Ethyl 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine-3-carboxylate, 95.0%, 5g

Vinyl terminated (15-17% diphenylsiloxane)-dimethylsiloxane copolymer, 10,000 cst, 100g

1-Naphthylamine Hydrochloride>98.0%(HPLC)25g